Basics Immunovant, Inc. IPO Date: June 7, 2019 Sector: Healthcare Industry: Biotech Market Cap: $2.99B Activated in VL: True Average Daily Range Avg Daily Range: $0.53 | 2.77% Avg Daily Range (30 D): $0.36 | 2.33% Avg Daily Range (90 D): $0.38 | 2.38% Institutional Daily Volume Avg Daily Volume: .83M Avg Daily Volume (30 D): 1.22M Avg Daily Volume (90 D): 1.07M Trade Size Avg Trade Size (Sh.): 78 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 63 Institutional Trades Total Inst.Trades: 2,762 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $1.9M Avg Inst. Trade (90 D): $2.38M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.45M Avg Closing Trade (30 D): $2.32M Avg Closing Trade (90 D): $2.81M Avg Closing Volume: 153.97K     News Sep 3, 2025 @ 10:17 PM Why Immunovant Stock Blasted Higher Today Source: Eric Volkman Sep 3, 2025 @ 4:57 PM Immunovant Unveils Durability and Treatment-Free S... Source: Immunovant, Inc. Aug 11, 2025 @ 11:27 AM Immunovant Posts 34% R&D Jump in Q1 Source: Jesterai Sep 9, 2024 @ 6:08 PM IMVT Stock Up on Upbeat Data From Graves' Disease ... Source: Zacks, Benzinga Contributor Sep 9, 2024 @ 7:55 AM Immunovant Provides Update on Graves’ Disea... Source: N/A Financials   TTM Q1 2026 Q4 2025 Basic EPS $-2.84 $-.71 Diluted EPS $-2.84 $-.71 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -447.3M $ -120.61M $ Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ 154.53M $ .57M $ PE Ratio